Dyadic Logo Current.jpg
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
26 mars 2024 08h30 HE | Dyadic International, Inc.
The first trial using a C1 produced monoclonal antibody provides equivalent protection against SARS-CoV-2 in hamster and nonhuman primate models compared to monoclonal antibody produced in CHO. ...
Dyadic Logo Current.jpg
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
21 févr. 2024 08h30 HE | Dyadic International, Inc.
JUPITER, Fla. and NES-ZIONA, Israel, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company specializing in advanced...
Dyadic Logo Current.jpg
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
13 févr. 2024 08h30 HE | Dyadic International, Inc.
JUPITER, Fla. and LELAND, N.C., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences®...
Dyadic Logo Current.jpg
Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company
06 févr. 2024 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company announced it has signed a...
Research Nester Logo.jpg
Contract Research Organization Market revenue to hit USD 108 Billion by 2035, says Research Nester
15 janv. 2024 06h00 HE | Research Nester
New York , Jan. 15, 2024 (GLOBE NEWSWIRE) -- The global contract research organization market size is slated to expand at 7% CAGR between 2023 and 2035. The market is poised to garner a revenue of...
Barinthus Bio Product Pipeline
Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones
05 janv. 2024 16h01 HE | Barinthus Biotherapeutics
Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones
Transparency Market Research
Immunoassay Market Set to Surge at 5.0% CAGR, to Reach USD 48.7 billion by 2031 | Transparency Market Research, Inc.
04 janv. 2024 10h30 HE | Transparency Market Research
Wilmington, Delaware, United States, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The immunoassay market was valued at US$ 31.5 billion in 2022. A CAGR of 5.0% is expected...
Research Nester Logo.jpg
Immunoprotein Diagnostic Testing Market revenue to hit USD 234 Billion by 2036, says Research Nester
06 déc. 2023 05h30 HE | Research Nester
New York, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The global immunoprotein diagnostic testing market size is predicted to grow at a CAGR of over ~7% from 2024 to 2036. The market is projected to garner a...
Emergen logo.png
Polymerase chain reaction Market Size Worth USD 19.24 Billion in 2032 | Emergen Research
21 nov. 2023 10h00 HE | Emergen Research
Vancouver, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The global polymerase chain reaction (PCR) market size was USD 8.50 Billion in 2022 and is expected to register a revenue CAGR of 8.5% during the...
OpGen.jpg
OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update
14 nov. 2023 16h30 HE | OpGen, Inc.
Total revenue for the first nine months of 2023 was approximately $2.35 million compared to approximately $1.89 million in the first nine months of 2022Implemented certain cash management initiatives,...